Entheon Biomedical

Company News

Canada Calls for Reformative Action in the Opioid Crisis

Canada Calls for Reformative Action in the Opioid Crisis

Canada appears to be taking a progressive yet patchworked community healthcare approach to alleviating the current opioid and substance-use crisis. But will this alleviate or reduce the number of barriers to safe and effective treatment, or do Canadian patients need and deserve more?

read more
The steep price of not treating Canada’s opioid crisis

The steep price of not treating Canada’s opioid crisis

The toll of the opioid crisis in Canada is multi-layered, affecting family and home life and rippling outward to our civic institutions and the economy as a whole. Learn more about these effects and how Entheon Biomedical sees hope through psychedelic-assisted therapy.

read more
Is 5-MeO-DMT an accompaniment to the treatment of substance use disorders?

Is 5-MeO-DMT an accompaniment to the treatment of substance use disorders?

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic substance that can be found in plants (Pachter et al. 1959), the secretion of the Incilius Alvarius toad (Weil and Davis 1994), and made synthetically (Hoshino 1936). The substance is well-known for its short-acting properties (depending on the route of administration) with subjective effects summarized in the following soundbite: ‘we are all on

read more
Overview of the worsening opioid crisis in Canada

Overview of the worsening opioid crisis in Canada

In the last six months, in the face of the COVID-19 pandemic, we have seen a spike in opioid overdoses, adding more layers of destruction and devastation on an already about isolated, uncertain, and grieving society due to the distancing measures, deaths and job losses that hallmarked this pandemic.

read more